Literature DB >> 19195520

Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly.

Morgan L Brown1, Joseph A Dearani, Gordon K Danielson, Frank Cetta, Heidi M Connolly, Carole A Warnes, Zhuo Li, David O Hodge, David J Driscoll.   

Abstract

Our objective was to determine the relative merits of using a bioprosthetic porcine valve (BPV) versus a mechanical valve (MechV) when tricuspid valve (TV) replacement is required in patients with Ebstein anomaly. From 1972 to 2006, 333 patients received a BPV and 45 received a MechV. Patient records were reviewed, vital status ascertained, and all patients not known to be deceased were mailed a medical questionnaire or contacted by telephone. Early mortality was not statistically higher for patients who had a MechV (11%) than for those who had a BPV (5%) inserted in the TV position (p = 0.173). The only independent preoperative predictor of operative mortality was moderate to severe left ventricular dysfunction (odds ratio 3.1, p = 0.03); 20-year survival was better in patients who had a BPV (75%) than for those who had a MechV (43%, p = 0.003). On multivariate analysis, after adjusting for ablation of accessory pathways, sinus rhythm at dismissal, and concomitant repair of pulmonary valve stenosis, a BPV remained a predictor of late survival (hazard ratio 0.42, p = 0.004). Survival free of reoperation on the TV at 20 years postoperatively was similar for patients who had a MechV (49%) compared with those who had a BPV (42%) inserted (p = 0.941). A greater percentage of patients who had a MechV reported endocarditis (12% vs 2%), bleeding requiring hospitalization (6% vs 3%), and thrombosis (12% vs 6%); however, none of these differences were statistically significant. In conclusion, a BPV in the tricuspid position was an independent predictor of improved survival. This may be related to the higher incidence of bleeding and thrombotic complications in the patients with MechVs or may be related to differences between the 2 groups. A BPV may offer superior late survival when compared with a MechV when TV replacement is required in patients with Ebstein anomaly, but patient selection must be individualized.

Entities:  

Mesh:

Year:  2008        PMID: 19195520     DOI: 10.1016/j.amjcard.2008.09.106

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  The ideal substitute for tricuspid valve replacement in patients with congenital heart disease: an unsolved dilemma.

Authors:  Andrea Garatti; Alessandro Giamberti; Alessandro Frigiola; Lorenzo Menicanti
Journal:  Transl Pediatr       Date:  2017-04

2.  Mid-term outcomes of individualized surgeries in patients with Ebstein's anomaly.

Authors:  Jiaquan Zhu; Li Zhang; Chunrong Bao; Fangjie Xu; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2019-03-08       Impact factor: 2.037

3.  Transcatheter valve implantation for degenerated tricuspid bioprosthesis and failed tricuspid ring.

Authors:  Shmuel Chen; Lyle Dershowitz; Isaac George
Journal:  Ann Cardiothorac Surg       Date:  2021-09

Review 4.  Surgical treatment for adult congenital heart disease: consideration for indications and procedures.

Authors:  Kozo Matsuo; Masashi Kabasawa; Soichi Asano; Shigeru Tateno; Yasutaka Kawasoe; Yoshitomo Okajima; Naoki Hayashida; Hirokazu Murayama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-08

5.  Diagnosis and management of ebstein anomaly of the tricuspid valve.

Authors:  Eric V Krieger; Anne Marie Valente
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

6.  Ebstein malformation of the tricuspid valve: current concepts in management and outcomes.

Authors:  Morgan L Brown; Joseph A Dearani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10

7.  Percutaneous valve in valve in the tricuspid position in a patient with Tetralogy of Fallot.

Authors:  Abhinay Challa; Ryan Markham; Darren Walters
Journal:  BMJ Case Rep       Date:  2017-08-02

8.  Cavotricuspid isthmus ablation using multimodality imaging in Ebstein anomaly with a mechanical tricuspid valve replacement.

Authors:  Sang Hyun Lee; Hyung Oh Choi; Ki Won Hwang
Journal:  HeartRhythm Case Rep       Date:  2018-05-09

9.  The better substitute for tricuspid valve replacement in patients with severe isolated tricuspid regurgitation.

Authors:  Weitao Liang; Honghua Yue; Tao Li; Xiaoli Qin; Yongjun Qian; Zhong Wu
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.